3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
2
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
477
Neoplasms
292
Breast Neoplasms
281
Colorectal Neoplasms
223
Neoplasm Metastasis
188
Prostatic Neoplasms
168
Ovarian Neoplasms
166
Lung Neoplasms
155
Multiple Myeloma
153
Recurrence
132
Melanoma
116
Pancreatic Neoplasms
115
Squamous Cell Carcinoma of Head and Neck
105
Endometrial Neoplasms
99
Stomach Neoplasms
98
Leukemia, Myeloid, Acute
97
Small Cell Lung Carcinoma
84
Leukemia, Lymphocytic, Chronic, B-Cell
83
Triple Negative Breast Neoplasms
81
Lymphoma, Non-Hodgkin
81
Carcinoma, Renal Cell
80
Carcinoma, Hepatocellular
77
Urinary Bladder Neoplasms
76
Lymphoma, Large B-Cell, Diffuse
72
Lymphoma, Follicular
64
Advanced Solid Tumors
64
Lymphoma
60
Glioblastoma
57
Parkinson Disease 4, Autosomal Dominant Lewy Body
56
Head and Neck Neoplasms
54
Interventions
vedolizumab
1
Photopheresis
1
Mycophenolic Acid
1
Methoxsalen
1
Infliximab
1
Azathioprine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Colitis
×
90 days
×
Clear all
NCT07619898
2026-06-02
PHOENIX-ECP
Therakos LLC
Phase 2
Not yet recruiting
112 enrolled